<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Vasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Ann Vasc Surg</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Annals of vascular surgery</journal-title></journal-title-group><issn pub-type="ppub">0890-5096</issn><issn pub-type="epub">1615-5947</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10799672</article-id><article-id pub-id-type="pmcid-ver">PMC10799672.319</article-id><article-id pub-id-type="pmcaid">10799672</article-id><article-id pub-id-type="pmcaiid">10799672</article-id><article-id pub-id-type="manuscript-id">NIHMS1950425</article-id><article-id pub-id-type="pmid">37225013</article-id><article-id pub-id-type="doi">10.1016/j.avsg.2023.05.002</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1950425</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1950425</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Differences in Long-Term Outcomes in End-Stage Kidney Disease Patients with Chronic Limb-Threatening Ischemia</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Rakestraw</surname><given-names initials="SL">Stephanie L.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Novak</surname><given-names initials="Z">Zdenek</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="MY">Michael Y.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Banks</surname><given-names initials="CA">Charles A.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Spangler</surname><given-names initials="EL">Emily L.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Levitan</surname><given-names initials="EB">Emily B.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Locke</surname><given-names initials="JE">Jayme E.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Beck</surname><given-names initials="AW">Adam W.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sutzko</surname><given-names initials="DC">Danielle C.</given-names></name></contrib><aff id="A1">Department of Surgery, University of Alabama at Birmingham, Birmingham, AL</aff></contrib-group><author-notes><fn fn-type="con" id="FN1"><p id="P1">Author contributions: S.R. was the primary author, contributed to study design, and performed statistical analysis. Z.N. assisted with study design, statistical analysis, and editing. M.W. provided assistance with statistical analysis and editing. C.B. provided editing assistance. E.S. provided editing and mentorship. E.L. provided statistical assistance, editing, and mentorship. J.L. provided editing and mentorship. A.B. provided editing and mentorship. D.S. assisted with study design, editing, and mentorship.</p></fn><corresp id="CR1">Correspondence to: Danielle C. Sutzko, MD, MS, Department of Surgery, 1808 7th Avenue South #503U, Birmingham, AL 35233, USA; <email>dsutzko@uabmc.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>22</day><month>5</month><year>2023</year></pub-date><volume>95</volume><issue-id pub-id-type="pmc-issue-id">453782</issue-id><fpage>162</fpage><lpage>168</lpage><pub-history><event event-type="nihms-submitted"><date><day>10</day><month>12</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>09</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>09</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-01 00:25:27.713"><day>01</day><month>09</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1950425.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P2">End-stage kidney disease (ESKD) is a risk factor for peripheral arterial disease and major adverse limb events following infra-inguinal bypass. Despite comprising an important patient population, ESKD patients are rarely analyzed as a subgroup and are underrepresented in vascular surgery guidelines. This study aims to compare the long-term outcomes of patients with and without ESKD undergoing endovascular peripheral vascular intervention (PVI) for chronic limb-threatening ischemia (CLTI).</p></sec><sec id="S2"><title>Methods:</title><p id="P3">CLTI patients with and without ESKD from 2007&#8212;2020 were identified in the Vascular Quality Initiative PVI dataset. Patients with prior bilateral interventions were excluded. Patients undergoing femoral-popliteal and tibial interventions were included. Mortality, reintervention, amputation, and occlusion rates at 21 months following intervention were examined. Statistical analyses were completed with the <italic toggle="yes">t</italic>-test, chi-square, and Kaplan-Meier curves.</p></sec><sec id="S3"><title>Results:</title><p id="P4">The ESKD cohort was younger (66.4 &#177; 11.8 vs. 71.6 &#177; 12.1 years, <italic toggle="yes">P</italic> &lt; 0.001) with higher rates of diabetes (82.2 vs. 60.9%, <italic toggle="yes">P</italic> &lt; 0.001) the non-ESKD cohort. Long-term follow-up was available for 58.4% (<italic toggle="yes">N</italic> = 2,128 procedures) of ESKD patients and 60.8% (<italic toggle="yes">N</italic> = 13,075 procedures) of non-ESKD patients. At 21 months, ESKD patients had a higher mortality (41.7 vs. 17.4%, <italic toggle="yes">P</italic> &lt; 0.001) and a higher amputation rate (22.3 vs. 7.1%, <italic toggle="yes">P</italic> &lt; 0.001); however, they had a lower reintervention rate (13.2 vs. 24.6%, <italic toggle="yes">P</italic> &lt; 0.001).</p></sec><sec id="S4"><title>Conclusions:</title><p id="P5">CLTI patients with ESKD have worse long-term outcomes at 2 years following PVI than non-ESKD patients. Mortality and amputation are higher with ESKD, while the reintervention rate is lower. Development of guidelines within the ESKD population has the potential to improve limb salvage.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>